Name: Malcolm West
Phone: (484) 580-8564
INTERNATIONAL LDN AWARENESS WEEK
October 19 – 25th, 2009
an old drug
a controversial treatment
successful across a range of diseases linked
by immune system dysfunction
YOU won't hear of it, and YOU won't be offered it
Bethesda, MD (PRWeb) October 1, 2009 -- International LDN Awareness Week begins when
researchers, physicians and advocates convene on October 19, 2009 at the
National Institutes of Health in Bethesda, MD, for the Fifth Annual
Conference on Low Dose Naltrexone. There is no charge for the conference;
participants register at
The aim of International LDN Awareness Week is to bring LDN out of the shadows, so more disease sufferers may benefit from the off-label use of this inexpensive generic drug.
Thousands of patients worldwide now enjoy improved health due to LDN. Most learn about it through word of mouth, success stories, Internet research, online forums, and a growing number of doctors who prescribe it for patients with autoimmune diseases. The LDN protocol employs approximately 1/10 the dose of naltrexone, a drug approved in 1984 by the FDA to treat alcoholism and drug addiction.
Low Dose Naltrexone (LDN) is changing
“Before I started taking LDN
in 2003, I was an invalid,” says Linda Elsegood, one of the founders of
LDN Research Trust,
a non-profit charity in England, which was formed in 2004 to raise both
awareness of and research for LDN. “I had just about every symptom of
Multiple Sclerosis that a person could have. I was constantly fatigued, I
had numbness over much of my body, a loss of hearing, twitching muscles,
vertigo. You name the symptom, and I had it.” Now, thanks to LDN, Linda is
almost back to normal, and works tirelessly to raise money and awareness of
LDN. “This drug has saved my life,” she says. “Along with hundreds of other
people, I am working hard to get the word out about LDN. Many patients who
don’t yet know about this drug, desperately need it.” Linda adds that LDN
has virtually no side effects – unlike most of the much costlier, highly
toxic medications doctors routinely prescribe to treat the disease.
Vicki Finlayson, of Auburn,
California, tells a story of a life that was filled with 9 years of
side-effect-laden medications approved by the FDA for MS. “I was on just
about every one of these medications,” she says, “and often, I was on
several at one time – along with medications for the pain. Yet, my MS was
getting progressively worse, until I was virtually bedridden.” Happily, in
2005, she found LDN, and she hasn’t looked back. “I felt improvement in two
days,” she says. She is now back to normal, and all of her symptoms are
gone. In fact, in May, 2008, she walked 53 miles to the
State Capitol Building in Sacramento to meet with state officials to
raise awareness about LDN. She will be back on the Capitol steps this
October 21st, as part of the ongoing effort to educate the
public, doctors and government officials about the importance of this
inexpensive, effective, patient-driven treatment. “LDN gave me my life back.
I feel that it’s very important to spread the word about it.” Because low
dose naltrexone treatment represents an inexpensive, off-label use for a
drug approved long ago by the FDA, pharmaceutical companies -- who carry out
most of today’s research on medications -- aren't much interested in funding
research on LDN.
But the incredible thing is that
hundreds of patients – and several doctors, too – who have experienced
remarkable results in themselves and in their patients, are conducting
research and raising money and awareness on their own. In fact, one group of
patients in the US raised enough money to help fund a successful trial at
the University of California in San Francisco, and there are now trials
being conducted in Mali, Africa, as well as in Milan, Italy.
Dr. Ian Zagon
and his colleagues at Penn State are doing both animal and human trials for
several disorders, including multiple sclerosis, Parkinson's disease and
various cancers; and
Stanford University is entering into a Phase II trial for fibromyalgia.
It is estimated that hundreds of doctors throughout the United States, the
UK and Canada, as well as in countries as far-reaching as Italy, Israel,
Australia, and even Nigeria, prescribe LDN for their patients.
LDN - CLINICAL PRACTICE AND RESEARCH:
The low dose naltrexone protocol
has a long history of success treating autoimmune diseases. Over 20 years
ago, naltrexone was approved by the FDA to treat addiction, at much higher
doses. But in 1982 Dr. Ian Zagon and other researchers at Penn State
University discovered its ability to normalize a dysfunctional immune
system, when used in very low doses. Bernard Bihari, MD, a Harvard
trained neurologist in New York City, observed positive clinical results
using LDN for HIV, MS and other immune system disorders. His observations
led to years of devoted work with patients, treating every kind of immune
disease -- including HIV/AIDS – with extremely positive results, and
virtually no side effects.
According to Dr. Bihari’s friend
and colleague, David Gluck, MD, who also works tirelessly to get the word
out about LDN: ““Low Dose Naltrexone may well be the most important
therapeutic breakthrough in over fifty years. It provides a safe and
inexpensive method of medical treatment by mobilizing the natural defenses
of one's own immune system.”
throughout the US, UK, Canada, Italy, Israel,
Australia and Nigeria prescribe LDN for their
The aim of International LDN Awareness
Week is to bring LDN out of the shadows, so more disease sufferers might
LDN RESESOURCES, WEBSITES, BOOKS & RADIO SHOW:
There are several key websites
devoted to LDN, including Dr. David Gluck’s site,
www.lowdosenaltrexone.org; and the websites of patient advocates, Linda
Elsegood and SammyJo Wilkinson,
www.ldners.org. All three of these
websites are dedicated to helping patients and funding research.
The following books & video have been produced on the topic of LDN:
International LDN Awareness Week eBook - 100 Testimonials.
- Cris Kerr’s freely shared
Those Who Suffer Much KNOW MUCH,
featuring a large collection of LDN testimonials
as case studies.
Up the Creek With a Paddle
by Mary Boyle Bradley.
- Free ebook by Julia Schopick,
The Faces of Low Dose Naltrexone.
Denial of Treatment
movie trailer &
LDN conference playbacks.
The Promise of Low Dose
Elaine Moore and SammyJo Wilkinson
Amazon search on "low dose naltrexone"
reveals 50 book titles that include references or
entire chapters devoted to LDN.
In addition, Mary Boyle Bradley
hosts a radio program on the very popular
Blog Talk Radio which is devoted solely to
discussing low dose naltrexone. Mary’s guests
include researchers, physicians and patient
advocates, and the show gets thousands of downloads
For more information on the USA
Conference, go to www.ProjectLDN.com, and for more information on International LDN
Awareness Week and LDN, please contact the following patient advocates: